Literature DB >> 3200838

Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells.

S D Young1, R S Marshall, R P Hill.   

Abstract

Cultured cells subjected to oxygen deprivation have been shown to undergo anomalous DNA synthesis, which can result in DNA overreplication and the generation of cellular variants [Rice, G. C., Hoy, C. & Schimke, R. T. (1986) Proc. Natl. Acad. Sci. USA 83, 5978-5982]. In the present study, murine tumor cells were exposed to severe hypoxia and then tested for their ability to form experimental metastases. Upon reoxygenation, cells transiently, yet dramatically, increased their metastatic potential. Flow cytometric analysis confirmed that hypoxia and reoxygenation induced cell cycle perturbations and DNA overreplication in these tumor cell lines. Fibrosarcoma cells with overreplicated DNA isolated by fluorescence-activated cell sorting proved to be highly metastatic, although cells with 2-4 times the haploid DNA content in populations treated with hypoxia were also markedly more metastatic than oxic populations. These results support the hypothesis that hypoxic conditions existing in regions of solid tumors promote cellular heterogeneity and tumor progression.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3200838      PMCID: PMC282788          DOI: 10.1073/pnas.85.24.9533

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Tumor necrosis and cell detachment.

Authors:  L Weiss
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

2.  Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

3.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

4.  Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo.

Authors:  M G Pallavicini; M E Lalande; R G Miller; R P Hill
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

5.  On the possibility of metabolic control of replicon "misfiring": relationship to emergence of malignant phenotypes in mammalian cell lineages.

Authors:  A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

6.  Relationship between aberrant DNA replication and loss of cell viability in Chinese hamster ovary CHO-K1 cells.

Authors:  D M Woodcock; J K Adams; I A Cooper
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Effect of immunomodulation on the fate of tumor cells in the central nervous system and systemic organs of mice. Distribution of [125I]5-Iodo-2'-deoxyuridine-labeled KHT tumor cells after left intracardial injection.

Authors:  F K Conley
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

8.  Enhanced metastatic potential of murine fibrosarcomas treated in vitro with ultraviolet radiation.

Authors:  M S Fisher; M A Cifone
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

9.  Loss and stabilization of amplified dihydrofolate reductase genes in mouse sarcoma S-180 cell lines.

Authors:  R J Kaufman; P C Brown; R T Schimke
Journal:  Mol Cell Biol       Date:  1981-12       Impact factor: 4.272

10.  Fifth Gordon Hamilton-Fairley memorial lecture. Methotrexate resistance and gene amplification: an experimental model for the generation of cellular heterogeneity.

Authors:  R T Schimke; A Hill; R N Johnston
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

View more
  121 in total

1.  Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.

Authors:  U Pilatus; E Ackerstaff; D Artemov; N Mori; R J Gillies; Z M Bhujwalla
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 2.  Tumor hypoxia and genetic alterations in sporadic cancers.

Authors:  Minoru Koi; Clement R Boland
Journal:  J Obstet Gynaecol Res       Date:  2011-01-27       Impact factor: 1.730

3.  Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Authors:  Heidi Högel; Krista Rantanen; Terhi Jokilehto; Reidar Grenman; Panu M Jaakkola
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

4.  Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2014-03-31       Impact factor: 5.852

Review 5.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 6.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response.

Authors:  S R McKeown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

7.  Cancer Stem Cells under Hypoxia as a Chemoresistance Factor in Breast and Brain.

Authors:  Spencer W Crowder; Daniel A Balikov; Yu-Shik Hwang; Hak-Joon Sung
Journal:  Curr Pathobiol Rep       Date:  2014-03

8.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Authors:  Dawen Zhao; Sophia Ran; Anca Constantinescu; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

9.  The anti-protozoan drug nifurtimox preferentially inhibits clonogenic tumor cells under hypoxic conditions.

Authors:  Quhuan Li; Qun Lin; Hoon Kim; Zhong Yun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

10.  Regulation of c-jun expression during hypoxic and low-glucose stress.

Authors:  W A Ausserer; B Bourrat-Floeck; C J Green; K R Laderoute; R M Sutherland
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.